These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 12078339

  • 1. [Treatment of ovarian cancer].
    Cianti C.
    Clin Ter; 2002; 153(2):135-44. PubMed ID: 12078339
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of epithelial ovarian cancer].
    Langmár Z, Csömör S.
    Orv Hetil; 2006 Aug 27; 147(34):1627-32. PubMed ID: 17017677
    [Abstract] [Full Text] [Related]

  • 3. Medical treatment of epithelial ovarian cancer.
    González-Martín AJ.
    Expert Rev Anticancer Ther; 2004 Dec 27; 4(6):1125-43. PubMed ID: 15606338
    [Abstract] [Full Text] [Related]

  • 4. [Latest information in the diagnoses of ovarian carcinoma].
    Isonishi S.
    Gan To Kagaku Ryoho; 2002 Aug 27; 29(8):1351-7. PubMed ID: 12214460
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis and management of epithelial ovarian cancer.
    Bhoola S, Hoskins WJ.
    Obstet Gynecol; 2006 Jun 27; 107(6):1399-410. PubMed ID: 16738170
    [Abstract] [Full Text] [Related]

  • 6. [Multidisciplinary treatment of recurrent epithelial ovarian carcinoma and prognostic analysis].
    Huang X, Cai SM, Tang J, Li ZT, Zang RY.
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep 27; 39(9):602-5. PubMed ID: 15498187
    [Abstract] [Full Text] [Related]

  • 7. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
    Milczek T, Klasa-Mazurkiewicz D, Emerich J, Kobierski J.
    Acta Obstet Gynecol Scand; 2009 Sep 27; 88(4):463-7. PubMed ID: 19235559
    [Abstract] [Full Text] [Related]

  • 8. [Impact of dose delivery of postoperative first-line chemotherapy on prognosis of stage III C epithelial ovarian carcinoma].
    Zhao XD, Zhang Q, Zhang Y.
    Ai Zheng; 2005 Aug 27; 24(8):1002-5. PubMed ID: 16086882
    [Abstract] [Full Text] [Related]

  • 9. Advances in the management of epithelial ovarian cancer.
    Berkenblit A, Cannistra SA.
    J Reprod Med; 2005 Jun 27; 50(6):426-38. PubMed ID: 16050567
    [Abstract] [Full Text] [Related]

  • 10. [Epithelial cancer of the ovary: current data].
    Ozols RF.
    Bull Cancer; 1993 Nov 27; 80(11):955-70. PubMed ID: 7915918
    [Abstract] [Full Text] [Related]

  • 11. Recent advances in the management of women with ovarian cancer.
    Eltabbakh GH.
    Minerva Ginecol; 2004 Feb 27; 56(1):81-9. PubMed ID: 14973412
    [Abstract] [Full Text] [Related]

  • 12. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
    Cicin I, Saip P, Eralp Y, Selam M, Topuz S, Ozluk Y, Aydin Y, Topuz E.
    Gynecol Oncol; 2008 Jan 27; 108(1):136-40. PubMed ID: 17936342
    [Abstract] [Full Text] [Related]

  • 13. [Ovarian carcinoma: current therapeutic aspects. A review].
    Buser K, Hänggi W, Greiner R, Schatzmann E.
    Schweiz Med Wochenschr; 1990 Nov 03; 120(44):1617-32. PubMed ID: 2251477
    [Abstract] [Full Text] [Related]

  • 14. Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective study.
    Pisano C, Greggi S, Tambaro R, Losito S, Iodice F, Di Maio M, Ferrari E, Falanga M, Formato R, Iaffaioli VR, Pignata S.
    Anticancer Res; 2005 Nov 03; 25(5):3501-5. PubMed ID: 16101169
    [Abstract] [Full Text] [Related]

  • 15. Systemic therapy in recurrent ovarian cancer: current treatment options and new drugs.
    Harter P, Hilpert F, Mahner S, Heitz F, Pfisterer J, du Bois A.
    Expert Rev Anticancer Ther; 2010 Jan 03; 10(1):81-8. PubMed ID: 20014888
    [Abstract] [Full Text] [Related]

  • 16. Update on the management of ovarian cancer.
    Ozols RF.
    Cancer J; 2002 Jan 03; 8 Suppl 1():S22-30. PubMed ID: 12075699
    [Abstract] [Full Text] [Related]

  • 17. Identification of prognostic factors after positive second-look surgery in epithelial ovarian carcinoma.
    McCreath WA, Eisenhauer EL, Abu-Rustum NR, Venkatraman ES, Caceres A, Bier R, Huh J, Cho J, Barakat RR, Chi DS.
    Gynecol Oncol; 2006 Jul 03; 102(1):8-14. PubMed ID: 16427689
    [Abstract] [Full Text] [Related]

  • 18. Ovarian cancer.
    Colombo N, Van Gorp T, Parma G, Amant F, Gatta G, Sessa C, Vergote I.
    Crit Rev Oncol Hematol; 2006 Nov 03; 60(2):159-79. PubMed ID: 17018256
    [Abstract] [Full Text] [Related]

  • 19. Extreme drug resistance assay results do not influence survival in women with epithelial ovarian cancer.
    Karam AK, Chiang JW, Fung E, Nossov V, Karlan BY.
    Gynecol Oncol; 2009 Aug 03; 114(2):246-52. PubMed ID: 19500821
    [Abstract] [Full Text] [Related]

  • 20. [Clinical efficacy analysis of chemotherapy to lymph node metastasis in epithelial ovarian cancer].
    Wu LY, Zhang R, Huang MN, Li N, Wang GX, Liu LY.
    Ai Zheng; 2003 Apr 03; 22(4):424-7. PubMed ID: 12704005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.